Privia Health Group, Inc. $PRVA Shares Bought by SG Americas Securities LLC

SG Americas Securities LLC grew its position in Privia Health Group, Inc. (NASDAQ:PRVA) by 102.3% in the first quarter, Holdings Channel.com reports. The fund owned 46,574 shares of the company’s stock after buying an additional 23,550 shares during the period. SG Americas Securities LLC’s holdings in Privia Health Group were worth $958,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in PRVA. Royal Bank of Canada lifted its stake in Privia Health Group by 63.5% during the first quarter. Royal Bank of Canada now owns 245,633 shares of the company’s stock worth $5,514,000 after purchasing an additional 95,371 shares during the last quarter. AQR Capital Management LLC boosted its holdings in Privia Health Group by 24.7% in the first quarter. AQR Capital Management LLC now owns 40,781 shares of the company’s stock worth $916,000 after purchasing an additional 8,068 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Privia Health Group by 3.2% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 118,764 shares of the company’s stock valued at $2,666,000 after purchasing an additional 3,714 shares during the last quarter. Intech Investment Management LLC increased its stake in Privia Health Group by 55.1% during the first quarter. Intech Investment Management LLC now owns 56,553 shares of the company’s stock valued at $1,270,000 after purchasing an additional 20,082 shares during the last quarter. Finally, Acadian Asset Management LLC acquired a new stake in shares of Privia Health Group during the first quarter worth $154,000. 94.48% of the stock is owned by institutional investors and hedge funds.

Privia Health Group Price Performance

Shares of PRVA opened at $27.36 on Friday. Privia Health Group, Inc. has a 12 month low of $18.77 and a 12 month high of $27.52. The stock has a fifty day moving average price of $23.45 and a 200 day moving average price of $23.02. The company has a market cap of $3.45 billion, a P/E ratio of 171.01, a PEG ratio of 2.16 and a beta of 0.83.

Privia Health Group (NASDAQ:PRVA) last posted its earnings results on Thursday, May 7th. The company reported $0.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.08 by $0.11. Privia Health Group had a return on equity of 2.81% and a net margin of 0.97%.The company had revenue of $603.85 million for the quarter, compared to analysts’ expectations of $560.99 million. During the same period last year, the business posted $0.22 earnings per share. The firm’s quarterly revenue was up 25.8% compared to the same quarter last year. As a group, research analysts anticipate that Privia Health Group, Inc. will post 0.27 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the stock. Barclays reduced their price target on shares of Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating on the stock in a research report on Tuesday, May 26th. Evercore set a $26.00 price objective on shares of Privia Health Group in a research report on Wednesday, April 8th. Weiss Ratings upgraded shares of Privia Health Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday. Finally, Canaccord Genuity Group cut their target price on shares of Privia Health Group from $35.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, May 8th. Eleven analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, Privia Health Group has a consensus rating of “Moderate Buy” and a consensus price target of $31.15.

Insider Buying and Selling

In other Privia Health Group news, Director Matthew Shawn Morris sold 63,212 shares of the business’s stock in a transaction dated Monday, June 29th. The shares were sold at an average price of $25.33, for a total transaction of $1,601,159.96. Following the completion of the transaction, the director directly owned 76,651 shares of the company’s stock, valued at $1,941,569.83. The trade was a 45.20% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO David Mountcastle sold 17,196 shares of the company’s stock in a transaction dated Friday, June 26th. The stock was sold at an average price of $25.18, for a total transaction of $432,995.28. Following the completion of the transaction, the chief financial officer owned 211,462 shares of the company’s stock, valued at approximately $5,324,613.16. This trade represents a 7.52% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 319,487 shares of company stock valued at $7,736,834 in the last quarter. Company insiders own 5.70% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.